Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pivotal Life Sciences is a global investment platform dedicated to the life sciences industry, managing a multi-billion dollar portfolio across various stages of company development. Formerly known as Nan Fung Life Sciences, the firm rebranded in 2021 to reflect its independent identity while remaining part of the Nan Fung Group. Pivotal invests in therapeutics, medical devices, and diagnostics, supporting companies from seed stage through to public markets. With offices in San Francisco and Hong Kong, the firm leverages a deep pool of capital and expertise to foster innovation in healthcare. The firm's investment strategy includes venture capital, growth equity, and public market investments, providing long-term support to its portfolio companies. Pivotal's team consists of experienced investment professionals and scientists who collaborate to identify and scale transformative medical technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pivotal Financial Consulting.